HPL demonstrates notable neuroprotective properties in cell-based models of Parkinson’s disease and amyotrophic lateral sclerosis, specifically in LUHMES and NSC-34 cell lines, respectively. This evidence concerns the gene LGALS1 and Parkinson disease.